Trinity Biotech (TRIB) Expected to Announce Earnings on Wednesday

Trinity Biotech (NASDAQ:TRIB) will likely be posting its quarterly earnings results before the market opens on Wednesday, January 29th. Analysts expect Trinity Biotech to post earnings of ($0.54) per share for the quarter.

Trinity Biotech Trading Down 2.3 %

Shares of TRIB stock opened at $0.76 on Tuesday. The firm has a market capitalization of $5.79 million, a price-to-earnings ratio of -0.34 and a beta of 1.01. The business’s 50-day moving average price is $0.94 and its 200-day moving average price is $1.64. Trinity Biotech has a 12 month low of $0.74 and a 12 month high of $3.55.

Trinity Biotech Company Profile

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes.